ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXPLORES HOW INCENTIVES COULD SUPPORT EFFECTIVENESS RESEARCH OF MEDICAL DEVICES

Published Nov 1, 2016
Vienna, Austria—1 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a workshop this morning on Incentivizing Research Into the Effectiveness of Medical Devices at the Society’s 19th Annual European Congress in Vienna, Austria.  The session was moderated by Rosanna Tarricone, PhD, Professor, Centre for Research on Health and Social Care Management, Bocconi University, Milan, Italy. Speakers for the session included:
  • Michael F. Drummond, MCom, DPhil, Professor of Health Economics, Centre for Health Economics, University of York, Heslington, York, UK
  • Mirella Marlow, MBA, MA, Programme Director, Devices and Diagnostics Systems, National Institute for Health and Clinical Excellence (NICE), London, UK
  • Adrian Griffin, MSc, Vice President, HTA and Reimbursement Policy, Johnson & Johnson, High Wycombe, UK
This issue panel examined how incentives could be utilized to increase the range and quality of effectiveness research of medical devices. Speakers noted that medical devices often gain market authorization with significantly less clinical effectiveness evidence than other health technologies, such as pharmaceuticals, because of the different legal requirements for approval of medical devices. The panel also remarked that post-market effectiveness research may actually be more important for medical devices than pharmaceuticals since the performance of the device often depends on the interaction with the user. Additional information on the ISPOR 19th Annual European Congress can be found here. Released presentations from the congress can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORVienna.

###

Related Stories

ISPOR Publishes Insights From Its First Global HTA Roundtable

Apr 21, 2025

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) published the insights from its first Global Health Technology Assessment (HTA) Roundtable in an article in the March/April issue of Value & Outcomes Spotlight.

Redefining Value in Care for Alzheimer's Disease and Dementia

Apr 8, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that provide crucial insights into the complex health economics of Alzheimer's disease and related dementias (ADRD), offering a roadmap for future research and policy as the aging population grows and novel treatments emerge.

ISPOR Celebrates Its 30-Year Anniversary

Mar 24, 2025

ISPOR—The Professional Society for Health Economics and Outcomes Research announced that it is celebrating its 30th anniversary in 2025.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×